Editors:
Comprehensive, clinically focused guide to the treatment of the most severely ill patients with schizophrenia
Informed by the latest research findings on neurobiology and treatment
Written by leading experts from Europe and the Americas
Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (13 chapters)
-
Front Matter
-
Back Matter
About this book
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.
In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
Reviews
“This book is an excellent collection of chapters that collectively comprise the clinical and scientific knowledge base about refractory schizophrenia. … For psychiatric practitioners, both prescribers and therapists, who manage schizophrenia on a daily basis, this book is a must own reference because of the wealth of helpful information between the covers.” (Henry A. Nasrallah, Journal of Clinical Psychiatry, Vol. 76 (9), September, 2015)
“This interesting book reviews treatment strategies and management options for those suffering from treatment-refractory schizophrenia (TRS). … The target audience includes psychiatrists and other mental health professionals. Any clinicians who treat severely ill patients with psychiatric disorders would benefit from reading this book. … This is an exceptional book covering a current critical issue for psychiatry and the patients suffering from unremitting psychosis. I highly recommend it.” (Michael Joel Schrift, Doody’s Book Reviews, July, 2014)Editors and Affiliations
-
Medical College of Georgia Dean’s Office, Georgia Regents University, Augusta, USA
Peter F. Buckley
-
Department of Psychosis Studies, Institute of Psychiatry, National Psychosis Unit, London, United Kingdom
Fiona Gaughran
Bibliographic Information
Book Title: Treatment–Refractory Schizophrenia
Book Subtitle: A Clinical Conundrum
Editors: Peter F. Buckley, Fiona Gaughran
DOI: https://doi.org/10.1007/978-3-642-45257-4
Publisher: Springer Berlin, Heidelberg
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2014
Hardcover ISBN: 978-3-642-45256-7Published: 01 April 2014
Softcover ISBN: 978-3-662-52387-2Published: 23 August 2016
eBook ISBN: 978-3-642-45257-4Published: 18 March 2014
Edition Number: 1
Number of Pages: VIII, 230
Number of Illustrations: 1 b/w illustrations, 6 illustrations in colour
Topics: Psychiatry, Clinical Psychology